Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,730.00
-140.00 (-2.04%)
At close: Mar 13, 2026

Finemedix Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
36,54778,252----
Enterprise Value
34,25380,482----
Last Close Price
6730.0014410.00----
PS Ratio
3.497.86----
PB Ratio
1.993.77----
P/TBV Ratio
2.013.79----
P/OCF Ratio
-458.48----
EV/Sales Ratio
3.278.08----
EV/EBITDA Ratio
-93.59----
Debt / Equity Ratio
0.160.190.340.480.660.74
Debt / EBITDA Ratio
-4.572.3318.71-32.23
Debt / FCF Ratio
--4.11---
Net Debt / Equity Ratio
-0.12-0.310.130.260.410.30
Net Debt / EBITDA Ratio
2.96-7.540.8810.04-3.3112.98
Net Debt / FCF Ratio
0.6515.271.55-1.41-5.03-0.58
Asset Turnover
0.500.440.550.420.350.45
Inventory Turnover
1.261.471.901.912.603.10
Quick Ratio
3.294.261.691.210.991.46
Current Ratio
5.475.372.481.851.471.81
Return on Equity (ROE)
-9.54%-0.14%9.72%2.15%-14.49%-14.19%
Return on Assets (ROA)
-5.27%-0.37%2.94%-2.13%-7.00%-1.16%
Return on Invested Capital (ROIC)
-10.68%-0.95%6.06%-3.63%-16.03%-2.86%
Return on Capital Employed (ROCE)
-8.20%-0.60%5.70%-4.50%-14.40%-2.00%
Earnings Yield
-3.95%-0.03%----
FCF Yield
-9.67%-0.54%----
Buyback Yield / Dilution
-13.80%-0.72%-1.75%-38.53%-9.53%21.07%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.